MAP2 and melanoma: Because BRAF oncogene levels appear to regulate melanoma neuronal differentiation and tumor progression, blockade of BRAF production with vemurafenib and forced MAP2 expression by demethylation with decitabine could induce apoptosis in metastatic melanoma [14].